Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | PROKR2 | Q8NFJ6 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10106587 | 0.85 | ALDH1A1 (0.37) | ALDH1A1KDM4ETSHRPROKR2MEN1 | |
| SCHEMBL565394 | 0.85 | PROKR2 (0.44) | ALDH1A1KDM4ETSHRPROKR2MEN1 | |
| SCHEMBL3518641 | 0.77 | ALDH1A1 (0.59) | ALDH1A1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL13039056 | 0.74 | ALDH1A1 (0.59) | ALDH1A1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL564098 | 0.74 | PROKR2 (0.57) | ALDH1A1KDM4ETSHRPROKR2MEN1 | |
| SCHEMBL13039536 | 0.73 | ALDH1A1 (0.58) | ALDH1A1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL13284402 | 0.72 | PROKR2 (0.46) | ALDH1A1KDM4ETSHRPROKR2 | |
| SCHEMBL3518923 | 0.71 | KDM4E (0.46) | ALDH1A1KDM4ETSHR | |
| SCHEMBL3516500 | 0.71 | KDM4E (0.46) | ALDH1A1KDM4ETSHR | |
| SCHEMBL13039464 | 0.69 | MTNR1A (0.51) | PROKR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120035149-A1 | Prokineticin Receptor Antagonists And Uses Thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035149-A1 | Prokineticin Receptor Antagonists And Uses Thereof | PROKR2, PROKR1, GIPR | ALDH1A1 4725/4885KDM4E 4874/4885TSHR 291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.